SCHEMBL2779595

SCHEMBL2779595

CNc1ccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GNG2 P59768 5/20 1.00
GNB1 P62873 5/20 1.00
PHLPP2 Q6ZVD8 2/20 0.77
CYP1A2 P05177 2/20 0.71
CYP2C9 P11712 2/20 0.71
ALOX15 P16050 2/20 0.71
HSD17B10 Q99714 2/20 0.71
P2RY4 P51582 8/20 0.68
ALDH1A1 P00352 1/20 0.67
CYP3A4 P08684 1/20 0.67
HPGD P15428 1/20 0.67
MAPK1 P28482 1/20 0.67
CYP2C19 P33261 1/20 0.67
HIF1A Q16665 1/20 0.67
P2RY2 P41231 9/20 0.64
P2RY12 Q9H244 6/20 0.64
P2RY6 Q15077 4/20 0.64
ENTPD1 P49961 2/20 0.64
MET P08581 2/20 0.63
HGF P14210 2/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13021512 0.94 GNG2 (0.92) GNG2GNB1PHLPP2CYP1A2CYP2C9
SCHEMBL9137161 0.90 GNG2 (0.82) GNG2GNB1PHLPP2CYP1A2CYP2C9
SCHEMBL2778161 0.90 GNG2 (1.00) GNG2GNB1PHLPP2CYP1A2CYP2C9
SCHEMBL13213975 0.90 GNG2 (0.86) GNG2GNB1PHLPP2CYP1A2CYP2C9
SCHEMBL29354288 0.90 GNG2 (1.00) GNG2GNB1PHLPP2CYP1A2CYP2C9
SCHEMBL791019 0.90 GNG2 (0.85) GNG2GNB1PHLPP2CYP1A2CYP2C9
SCHEMBL29357302 0.90 GNG2 (0.85) GNG2GNB1PHLPP2CYP1A2CYP2C9
SCHEMBL8779914 0.90 GNG2 (0.81) GNG2GNB1PHLPP2CYP1A2CYP2C9
SCHEMBL11321111 0.90 GNG2 (0.81) GNG2GNB1PHLPP2CYP1A2CYP2C9
SCHEMBL9512742 0.89 GNG2 (0.80) GNG2GNB1PHLPP2CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100130505-A1 COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING UNIVERSITY OF ROCHESTER (US) 2010-05-27 US claimed
EP-2147310-A2 COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING University of Rochester (US) 2010-01-27 EP claimed
WO-2009020677-A9 COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING UNIV ROCHESTER (US) 2009-04-16 WO claimed
WO-2009020677-A2 COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING UNIVERSITY OF ROCHESTER (US) 2009-02-12 WO claimed
US-8975259-B2 Compositions and methods for inhibiting G protein signaling UNIVERSITY OF ROCHESTER (US) 2015-03-10 US disclosed
EP-0230045-B1 PROCESS FOR DYEING POLYAMIDE FIBRES BAYER AG (DE) 1991-01-16 EP disclosed
US-4773914-A Process for trichromatic dyeing polyamide fibres BAYER AKTIENGESELLSCHAFT (DE) 1988-09-27 US disclosed
US-4242259-A TRIAZINE DYES, COTTON BAYER AKTIENGESELLSCHAFT (DE) 1980-12-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130505-A1 COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING GNAI1, GNAI3, GNAI2 GNG2 5/4885GNB1 4/4885PHLPP2 200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.